Description
Samabriva is a biotechnology company that has developed an automated, proprietary bioproduction system available to companies seeking to produce high-value molecules using plants. This innovative approach positions Samabriva as a contributor to the Active Pharmaceutical Ingredients (API) market, catering specifically to the needs of the pharmaceutical industry.
Services include:
– Contract Manufacturing (CMO/CDMO)
– Bioproduction of high-value molecules
– Custom synthesis of active ingredients
– Process development and optimisation
– Scale-up support for production
With its advanced bioproduction capabilities, Samabriva is dedicated to delivering quality and efficiency in pharmaceutical manufacturing. For further details, please visit samabriva.com.
Contact Information
Related Listings

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl

External Manufacturing Leaders Basel 2026
Exclusive event for senior external manufacturing leaders. Basel










